Developing a faster-acting treatment for high-altitude affliction

Pulmonary edema is a significant risk for anyone spending time at high altitudes, and also affects people with chronic conditions including congestive heart failure. Researchers show an inhalable form of the drug Ambrisentan could offer a faster-acting treatment option for this life-threatening condition.